Long-term single antiplatelet therapy for patients with acute coronary syndrome at high-risk for ischemia and bleeding: a precision cohort study - Poll - MDSpire

Long-term single antiplatelet therapy for patients with acute coronary syndrome at high-risk for ischemia and bleeding: a precision cohort study

  • By

  • Ma Wanda

  • Lei Mengjie

  • Wang Jingyao

  • Sun Xue

  • Wang Xiao

  • Li Cairong

  • Li Yachao

  • Zhao Zhigang

  • Xue Zengming

  • May 1, 2026

  • 0 min

Share

Original Source(s)

Long-term single antiplatelet therapy for patients with acute coronary syndrome at high-risk for ischemia and bleeding: a precision cohort study

  • by Ma Wanda, Lei Mengjie, Wang Jingyao, Sun Xue, Wang Xiao, Li Cairong, Li Yachao, Zhao Zhigang, Xue Zengming

  • May 1, 2026

Related Content

Long COVID May Raise Cardiovascular Risk

Population-based cohort shows higher rates of cardiac arrhythmias and coronary artery disease following nonhospitalized infections, with sex-specific differences.

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

Syphilis Linked to Adverse Cardiovascular Outcomes

Matched cohort study shows higher risks across vascular events and mortality